COVID-19: Advertising Responsibly
The ASA continues its drive to ensure responsible advertising during the COVID-19 pandemic.
At the outset of the pandemic the ASA took swift action to highlight to advertisers it would act quickly and robustly against ads that exploited people’s health related anxieties and the difficult financial or employment circumstances many people were facing. The ASA also published guidance on the main areas in which it believed ads may be deemed problematic. Despite this there have been a number of ads which have fallen foul of the CAP Code.
The latest series of problematic ads related to a vitamin C drink containing claims such as “Vitamin-C has been proven to boost immunity” which, taken in the midst of the pandemic, could be taken to imply that the drink could help to prevent, treat or cure COVID-19. Making such claims is not permitted unless the products in question are authorised on the EU Register of nutrition and health claims, which this product was not. It is also prohibited to make claims that food and supplements can prevent, treat or cure human disease. The ASA therefore held that the ads must not appear again.
Below we have outlined the ASA guidance and rulings since the beginning of the pandemic to highlight the main areas of concern which may have the potential to grossly undermine the UK’s response to the pandemic.
Key Areas of concern and ASA Rulings
1. Medicines and medical devices:
The key issue in this space is that ‘medical or medicinal claims’ can only be made for products where they are licenced medicines or appropriately marked medical devices.
- The ASA banned an ad which promoted an “Anti-Corona Virus Face Mask”.
- The ASA banned a series of ads which promoted a “New Nano Tech Face Mask” and implied that the mask would offer protection against being infected by COVID-19.
2. Alternative and complementary therapies
The ASA made clear that it was likely to consider COVID-19 a condition for which medical supervision should be sought.
- The ASA banned advertising claims on websites and in social media made by three clinics offering IV drip treatments which made medicinal claims that implied they could prevent or treat COVID-19.
3. Food or food supplements
As seen above, the ASA made clear that ads that make health related claims and/or suggest a product may help protect consumers from infection of COIVD-19 by, for example, supporting their immune system, were likely to be viewed as problematic.
4. Fear, distress and social responsibility
The ASA highlighted that ads should not exploit an audience’s fear in order to mislead them into buying a product.
- The ASA banned an ad which stated “British Build, beds proudly made in the UK. No Nasty imports”. The ad also contained imagery whereby a cartoon mattress was wearing a green surgical mask. In the ASA’s view the ad was likely to cause serious or widespread offence as in combination with the image the reference to “nasty imports” was likely to be read as a negative reference to immigration or race.
Ads in any of the special interest areas above will likely receive additional scrutiny from both the public and regulators. Advertisers must exercise special caution and be mindful of how ads may be perceived by the public in the current heightened state of awareness, especially if those ads contain health-related claims.
For more information on any of the ASA Rulings set out above, please use the following link.
When can you set off claims against different elements of a project
The Court’s decision raises important drafting considerations for construction contracts involving multiple elements of a project.
Drafting terms and conditions or negotiating a contract? Be wary of "unusual" and "exorbitant" exclusion clauses
When drafting a set of terms and conditions, companies must adhere to the requirements contained in the Unfair Contract Terms Act 1977
Stop, collaborate and listen: Top 10 Tips with Collaboration Agreements
Providing you with the top ten tips on collaboration agreements - what should you know?
Fiona Edmond and Mark Smith write for Property Week on data centres as an infrastructure asset class
The complexity of operational issues is something those new to the sector may not anticipate and interest is likely to increase.
Preparing your company for sale
We set out here some initial steps to consider in anticipation of a sale.
ESG investment and the challenges for trustees
What challenges does the ESG revolution present for trustees of private family trusts?
The impact of COVID-19 on commercial and residential tenancies
What impact has COVID-19 had on commercial and residential tenancies? Read more here.
Charles Russell Speechlys advises discoverIE on its acquisition of Antenova
discoverIE is a leading international designer, manufacturer and supplier of customised electronics to industry.
Q&A: Separate blocks, common parts and enfranchisement
Miriam Seitler and Lauren Fraser answer queries relating to leaseholders seeking to acquire the freehold.
Coded messages for landlords and tenants
“What does the code of practice mean for landlords and tenants? Read more here”
The family court’s role in micro managing 'trivial' disputes
The recent decision has dealt with the family court’s role in micro managing “trivial” disputes in relation to children
Gareth Mills writes for Lexology Getting The Deal Through on technology disputes in Bahrain
The most common disputes occur following perceived or actual failures to deliver required technology services an lack of clarity.
Taxing horizons and fiscal black holes
A super-massive black hole at the centre of the nation’s finances means that tax reform and rates rises look increasingly likely.
Charles Russell Speechlys advises Acora on acquisition of Westgate IT
Westgate IT specialises in providing IT support to businesses in the South West.
Jason Saiban writes for Food Manufacture on the food industry's climate change challenge
The key challenge will be how the environmental targets are actually met.
Q&A: Wrestling with restrictive covenants
Camilla Lamont (barrister at Landmark Chambers) and Real Estate Disputes Partner Emma Humphreys answer a pair of covenant queries
Charles Russell Speechlys advises Grape Paradise on the acquisition of a fine wine business
Charles Russell Speechlys has advised Grape Paradise on the acquisition of the Sarment Group in the China Mainland territories.
Grab the tail by the horns - Why is tail spend so critical in today’s outsourced portfolio?
It’s usually invisible, but in all likelihood, you’ve got tail spend.
Collateral Warranties – Are they also a ‘Construction Contract’?
What are collateral warranties and what do they mean for your construction contracts? Read more here.
eCommerce and the Post-Brexit State of Play
Key UK and EU legislation governing how online platforms deal with consumers and their business users.